Acknowledgement
This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) & funded by the Korean government (MSIT) (No. 2021M3A9H3015688).
References
- Alexander, J.L., Wilson, I.D., Teare, J., Marchesi, J.R., Nicholson, J.K., and Kinross, J.M. (2017). Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat. Rev. Gastroenterol. Hepatol. 14, 356-365. https://doi.org/10.1038/nrgastro.2017.20
- Baruch, E.N., Youngster, I., Ben-Betzalel, G., Ortenberg, R., Lahat, A., Katz, L., Adler, K., Dick-Necula, D., Raskin, S., Bloch, N., et al. (2021). Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science 371, 602-609. https://doi.org/10.1126/science.abb5920
- Choi, J. and Lee, S.Y. (2020). Clinical characteristics and treatment of immune-related adverse events of immune checkpoint inhibitors. Immune Netw. 20, e9. https://doi.org/10.4110/in.2020.20.e9
- Coleman, R.L., Monk, B.J., Sood, A.K., and Herzog, T.J. (2013). Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat. Rev. Clin. Oncol. 10, 211-224. https://doi.org/10.1038/nrclinonc.2013.5
- Daillere, R., Vetizou, M., Waldschmitt, N., Yamazaki, T., Isnard, C., PoirierColame, V., Duong, C.P.M., Flament, C., Lepage, P., Roberti, M.P., et al. (2016). Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity 45, 931-943. https://doi.org/10.1016/j.immuni.2016.09.009
- Davar, D., Dzutsev, A.K., McCulloch, J.A., Rodrigues, R.R., Chauvin, J.M., Morrison, R.M., Deblasio, R.N., Menna, C., Ding, Q., Pagliano, O., et al. (2021). Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science 371, 595-602. https://doi.org/10.1126/science.abf3363
- Finlay, B.B., Goldszmid, R., Honda, K., Trinchieri, G., Wargo, J., and Zitvogel, L.J.N.R.I. (2020). Can we harness the microbiota to enhance the efficacy of cancer immunotherapy? Nat. Rev. Immunol. 20, 522-528. https://doi.org/10.1038/s41577-020-0374-6
- Gaiser, R.A., Halimi, A., Alkharaan, H., Lu, L., Davanian, H., Healy, K., Hugerth, L.W., Ateeb, Z., Valente, R., Fernandez Moro, C., et al. (2019). Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. Gut 68, 2186-2194. https://doi.org/10.1136/gutjnl-2018-317458
- Garcia-Gonzalez, A.P., Ritter, A.D., Shrestha, S., Andersen, E.C., Yilmaz, L.S., and Walhout, A.J.M. (2017). Bacterial metabolism affects the C. elegans response to cancer chemotherapeutics. Cell 169, 431-441.e8. https://doi.org/10.1016/j.cell.2017.03.046
- GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1545-1602. https://doi.org/10.1016/S0140-6736(16)31678-6
- Geller, L.T., Barzily-Rokni, M., Danino, T., Jonas, O.H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z.A., Shee, K., et al. (2017). Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357, 1156-1160. https://doi.org/10.1126/science.aah5043
- Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., Prieto, P.A., Vicente, D., Hoffman, K., Wei, S.C., et al. (2018). Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97-103. https://doi.org/10.1126/science.aan4236
- Hashim, D., Boffetta, P., La Vecchia, C., Rota, M., Bertuccio, P., Malvezzi, M., and Negri, E. (2016). The global decrease in cancer mortality: trends and disparities. Ann. Oncol. 27, 926-933. https://doi.org/10.1093/annonc/mdw027
- Hsieh, Y.Y., Tung, S.Y., Pan, H.Y., Yen, C.W., Xu, H.W., Lin, Y.J., Deng, Y.F., Hsu, W.T., Wu, C.S., and Li, C. (2018). Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan. Sci. Rep. 8, 158. https://doi.org/10.1038/s41598-017-18596-0
- Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R.A., Molina, D.A., Salcedo, R., Back, T., Cramer, S., et al. (2013). Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967-970. https://doi.org/10.1126/science.1240527
- Iizumi, T., Battaglia, T., Ruiz, V., and Perez Perez, G.I. (2017). Gut microbiome and antibiotics. Arch. Med. Res. 48, 727-734. https://doi.org/10.1016/j.arcmed.2017.11.004
- Jacouton, E., Michel, M.L., Torres-Maravilla, E., Chain, F., Langella, P., and Bermudez-Humaran, L.G. (2018). Elucidating the immune-related mechanisms by which probiotic strain Lactobacillus casei BL23 displays anti-tumoral properties. Front. Microbiol. 9, 3281. https://doi.org/10.3389/fmicb.2018.03281
- Jan, G., Belzacq, A.S., Haouzi, D., Rouault, A., Metivier, D., Kroemer, G., and Brenner, C. (2002). Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ. 9, 179-188. https://doi.org/10.1038/sj.cdd.4400935
- Jandhyala, S.M., Talukdar, R., Subramanyam, C., Vuyyuru, H., Sasikala, M., and Nageshwar Reddy, D. (2015). Role of the normal gut microbiota. World J. Gastroenterol. 21, 8787-8803. https://doi.org/10.3748/wjg.v21.i29.8787
- Ji, B. and Nielsen, J. (2015). From next-generation sequencing to systematic modeling of the gut microbiome. Front. Genet. 6, 219.
- Jung, J., Surh, C.D., and Lee, Y.J. (2019). Microbial colonization at early life promotes the development of diet-induced CD8αβ intraepithelial T cells. Mol. Cells 42, 313-320. https://doi.org/10.14348/molcells.2019.2431
- Kim, C.H., Park, J., and Kim, M. (2014). Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. Immune Netw. 14, 277-288. https://doi.org/10.4110/in.2014.14.6.277
- Kodawara, T., Higashi, T., Negoro, Y., Kamitani, Y., Igarashi, T., Watanabe, K., Tsukamoto, H., Yano, R., Masada, M., Iwasaki, H.J.B., et al. (2016). The inhibitory effect of ciprofloxacin on the β-glucuronidase-mediated deconjugation of the irinotecan metabolite SN-38-G. Basic Clin. Pharmacol. Toxicol. 118, 333-337. https://doi.org/10.1111/bcpt.12511
- Konishi, H., Fujiya, M., Tanaka, H., Ueno, N., Moriichi, K., Sasajima, J., Ikuta, K., Akutsu, H., Tanabe, H., and Kohgo, Y. (2016). Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nat. Commun. 7, 12365. https://doi.org/10.1038/ncomms12365
- Ku, K., Park, I., Kim, D., Kim, J., Jang, S., Choi, M., Choe, H.K., and Kim, K. (2020). Gut microbial metabolites induce changes in circadian oscillation of clock gene expression in the mouse embryonic fibroblasts. Mol. Cells 43, 276-285. https://doi.org/10.14348/molcells.2020.2309
- Kuen, D.S., Kim, B.S., and Chung, Y. (2020). IL-17-producing cells in tumor immunity: friends or foes? Immune Netw. 20, e6. https://doi.org/10.4110/in.2020.20.e6
- Laborda-Illanes, A., Sanchez-Alcoholado, L., Dominguez-Recio, M.E., Jimenez-Rodriguez, B., Lavado, R., Comino-Mendez, I., Alba, E., and Queipo-Ortuno, M.I. (2020). Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment. Cancers (Basel) 12, 2465. https://doi.org/10.3390/cancers12092465
- Lee, S.H., Cho, S.Y., Yoon, Y., Park, C., Sohn, J., Jeong, J.J., Jeon, B.N., Jang, M., An, C., Lee, S., et al. (2021). Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice. Nat. Microbiol. 6, 277-288. https://doi.org/10.1038/s41564-020-00831-6
- Lehouritis, P., Cummins, J., Stanton, M., Murphy, C.T., McCarthy, F.O., Reid, G., Urbaniak, C., Byrne, W.L., and Tangney, M. (2015). Local bacteria affect the efficacy of chemotherapeutic drugs. Sci. Rep. 5, 14554. https://doi.org/10.1038/srep14554
- Long, X., Wong, C.C., Tong, L., Chu, E.S.H., Ho Szeto, C., Go, M.Y.Y., Coker, O.O., Chan, A.W.H., Chan, F.K.L., Sung, J.J.Y., et al. (2019). Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity. Nat. Microbiol. 4, 2319-2330. https://doi.org/10.1038/s41564-019-0541-3
- Louis, P., Hold, G.L., and Flint, H.J. (2014). The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661-672. https://doi.org/10.1038/nrmicro3344
- Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.L., Luke, J.J., and Gajewski, T.F.J.S. (2018). The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359, 104-108. https://doi.org/10.1126/science.aao3290
- Miller, K.D., Nogueira, L., Mariotto, A.B., Rowland, J.H., Yabroff, K.R., Alfano, C.M., Jemal, A., Kramer, J.L., and Siegel, R.L. (2019). Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 69, 363-385. https://doi.org/10.3322/caac.21565
- Nevala-Plagemann, C., Hidalgo, M., and Garrido-Laguna, I. (2020). From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer. Nat. Rev. Clin. Oncol. 17, 108-123. https://doi.org/10.1038/s41571-019-0281-6
- Panek, M., Cipcic Paljetak, H., Baresic, A., Peric, M., Matijasic, M., Lojkic, I., Vranesic Bender, D., Krznaric, Z., and Verbanac, D. (2018). Methodology challenges in studying human gut microbiota - effects of collection, storage, DNA extraction and next generation sequencing technologies. Sci. Rep. 8, 5143. https://doi.org/10.1038/s41598-018-23296-4
- Pflug, N., Kluth, S., Vehreschild, J.J., Bahlo, J., Tacke, D., Biehl, L., Eichhorst, B., Fischer, K., Cramer, P., Fink, A.M., et al. (2016). Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. Oncoimmunology 5, e1150399. https://doi.org/10.1080/2162402X.2016.1150399
- Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillere, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M.P., et al. (2018). Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91-97. https://doi.org/10.1126/science.aan3706
- Roy, S. and Trinchieri, G. (2017). Microbiota: a key orchestrator of cancer therapy. Nat. Rev. Cancer 17, 271-285. https://doi.org/10.1038/nrc.2017.13
- Rubinstein, M.R., Wang, X., Liu, W., Hao, Y., Cai, G., and Han, Y.W. (2013). Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195-206. https://doi.org/10.1016/j.chom.2013.07.012
- Scott, T.A., Quintaneiro, L.M., Norvaisas, P., Lui, P.P., Wilson, M.P., Leung, K.Y., Herrera-Dominguez, L., Sudiwala, S., Pessia, A., Clayton, P.T., et al. (2017). Host-microbe co-metabolism dictates cancer drug efficacy in C. elegans. Cell 169, 442-456.e18. https://doi.org/10.1016/j.cell.2017.03.040
- Sekirov, I., Russell, S.L., Antunes, L.C., and Finlay, B.B. (2010). Gut microbiota in health and disease. Physiol. Rev. 90, 859-904. https://doi.org/10.1152/physrev.00045.2009
- Selwyn, F.P., Cui, J.Y., and Klaassen, C.D. (2015). RNA-Seq quantification of hepatic drug processing genes in germ-free mice. Drug Metab. Dispos. 43, 1572-1580. https://doi.org/10.1124/dmd.115.063545
- Sender, R., Fuchs, S., and Milo, R. (2016). Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533. https://doi.org/10.1371/journal.pbio.1002533
- Sethi, V., Kurtom, S., Tarique, M., Lavania, S., Malchiodi, Z., Hellmund, L., Zhang, L., Sharma, U., Giri, B., Garg, B., et al. (2018). Gut microbiota promotes tumor growth in mice by modulating immune response. Gastroenterology 155, 33-37.e6. https://doi.org/10.1053/j.gastro.2018.04.001
- Shin, J.M., Luo, T., Kamarajan, P., Fenno, J.C., Rickard, A.H., and Kapila, Y.L. (2017). Microbial communities associated with primary and metastatic head and neck squamous cell carcinoma - a high fusobacterial and low streptococcal signature. Sci. Rep. 7, 9934. https://doi.org/10.1038/s41598-017-09786-x
- Shui, L., Yang, X., Li, J., Yi, C., Sun, Q., and Zhu, H. (2019). Gut microbiome as a potential factor for modulating resistance to cancer immunotherapy. Front. Immunol. 10, 2989. https://doi.org/10.3389/fimmu.2019.02989
- Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., Benyamin, F.W., Lei, Y.M., Jabri, B., Alegre, M.L., et al. (2015). Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084-1089. https://doi.org/10.1126/science.aac4255
- Takagi, A., Ikemura, H., Matsuzaki, T., Sato, M., Nomoto, K., Morotomi, M., and Yokokura, T. (2008). Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse. J. Gastroenterol. 43, 661-669. https://doi.org/10.1007/s00535-008-2212-7
- Tanoue, T., Morita, S., Plichta, D.R., Skelly, A.N., Suda, W., Sugiura, Y., Narushima, S., Vlamakis, H., Motoo, I., Sugita, K., et al. (2019). A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature 565, 600-605. https://doi.org/10.1038/s41586-019-0878-z
- Tomasetti, C. and Vogelstein, B. (2015). Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347, 78-81. https://doi.org/10.1126/science.1260825
- Uribe-Herranz, M., Rafail, S., Beghi, S., Gil-de-Gomez, L., Verginadis, I., Bittinger, K., Pustylnikov, S., Pierini, S., Perales-Linares, R., Blair, I.A., et al. (2020). Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. J. Clin. Invest. 130, 466-479. https://doi.org/10.1172/jci124332
- Vetizou, M., Pitt, J.M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M.P., Duong, C.P., et al. (2015). Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079-1084. https://doi.org/10.1126/science.aad1329
- Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillere, R., Hannani, D., Enot, D.P., Pfirschke, C., Engblom, C., Pittet, M.J., et al. (2013). The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971-976. https://doi.org/10.1126/science.1240537
- Waldmann, T.A. (2003). Immunotherapy: past, present and future. Nat. Med. 9, 269-277. https://doi.org/10.1038/nm0303-269
- Wallace, B.D., Wang, H., Lane, K.T., Scott, J.E., Orans, J., Koo, J.S., Venkatesh, M., Jobin, C., Yeh, L.A., Mani, S., et al. (2010). Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831-835. https://doi.org/10.1126/science.1191175
- Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., and Zhao, L. (2012). Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6, 320-329. https://doi.org/10.1038/ismej.2011.109
- Wong, S.H., Kwong, T.N.Y., Wu, C.Y., and Yu, J. (2019). Clinical applications of gut microbiota in cancer biology. Semin. Cancer Biol. 55, 28-36. https://doi.org/10.1016/j.semcancer.2018.05.003
- Wu, S., Rhee, K.J., Zhang, M., Franco, A., and Sears, C.L. (2007). Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. J. Cell Sci. 120(Pt 11), 1944-1952. https://doi.org/10.1242/jcs.03455
- Xu, C., Ruan, B., Jiang, Y., Xue, T., Wang, Z., Lu, H., Wei, M., Wang, S., Ye, Z., Zhai, D.J.B., et al. (2017). Antibiotics-induced gut microbiota dysbiosis promotes tumor initiation via affecting APC-Th1 development in mice. Biochem. Biophys. Res. Commun. 488, 418-424. https://doi.org/10.1016/j.bbrc.2017.05.071
- Yamamura, K., Baba, Y., Nakagawa, S., Mima, K., Miyake, K., Nakamura, K., Sawayama, H., Kinoshita, K., Ishimoto, T., Iwatsuki, M., et al. (2016). Human microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin. Cancer Res. 22, 5574-5581. https://doi.org/10.1158/1078-0432.CCR-16-1786
- Yu, A.I., Zhao, L., Eaton, K.A., Ho, S., Chen, J., Poe, S., Becker, J., Gonzalez, A., McKinstry, D., Hasso, M., et al. (2020). Gut microbiota modulate CD8 T cell responses to influence colitis-associated tumorigenesis. Cell Rep. 31, 107471. https://doi.org/10.1016/j.celrep.2020.03.035
- Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017). Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170, 548-563.e16. https://doi.org/10.1016/j.cell.2017.07.008
- Yuan, L., Zhang, S., Li, H., Yang, F., Mushtaq, N., Ullah, S., Shi, Y., An, C., and Xu, J. (2018). The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer. Biomed. Pharmacother. 108, 184-193. https://doi.org/10.1016/j.biopha.2018.08.165
- Zhu, Q., Gao, R., Wu, W., and Qin, H. (2013). The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biol. 34, 1285-1300. https://doi.org/10.1007/s13277-013-0684-4
- Zitvogel, L., Galluzzi, L., Viaud, S., Vetizou, M., Daillere, R., Merad, M., and Kroemer, G. (2015). Cancer and the gut microbiota: an unexpected link. Sci. Transl. Med. 7, 271ps1.